Trimethaphan camsylate
Arfonad (trimethaphan camsylate) is a small molecule pharmaceutical. Trimethaphan camsylate was first approved as Arfonad on 1982-01-01. It is used to treat aortic aneurysm, malignant hypertension, and pulmonary edema in the USA.
| Trade Name | Arfonad |
|---|---|
| Common Name | Trimethaphan camsylate |
| Indication | aortic aneurysm, malignant hypertension, pulmonary edema |
| Drug Class |
